CDK4/6 inhibitors

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930

CDK4/6 inhibitors
Jun 14, 2024, 09:30 | Blog
Upcoming webinar on "Overcoming Resistance" led by Michael Wick - The START Center for Cancer Research
The START Center for Cancer Research shared on LinkedIn:       . "Don't miss our…
May 31, 2024, 10:41 | Blog
Jason A. Mouabbi: Here are my anticipated Top 3 breast cancer presentations for ASCO24
Jason A. Mouabbi, Breast Medical Oncologist at MD Anderson Cancer Center, shared a post on X:…
May 26, 2024, 06:49 | Societies
Paolo Tarantino: Less than a week to what promises to be a terrific ASCO24
Paolo Tarantino recently shared a post on X: "Less than a week to what promises…
May 24, 2024, 14:53 | Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 15, 2024, 09:03 | Blog
Stephanie Graff: Honored to join Wolfgang Janni and Carlos Barrios at ESMO Breast 24
Stephanie Graff shared a post on X: “Leaving soon for ESMO Breast 24. Honored to…
Apr 3, 2024, 13:35 | Insight
Kefah Mokbel: Insights into the management of Leptomeningeal Disease and clinical outcomes
Kefah Mokbel, Chair of The Multidisciplinary Breast Cancer Program at London Breast Institute, shared on…
Apr 2, 2024, 18:47 | Drugs
A Reflection on a Decade-Long Clinical Trial by Wafik S. El-Deiry
Wafik S. El-Deiry, Director at the Legorreta Cancer Center at Brown University, shared a post…
Mar 21, 2024, 10:46 | Insight
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence - UCLA Health
Drug regimen significantly improves invasive disease-free survival for patients with stage 2 or 3 HR-positive,…
Dec 14, 2023, 16:23 | Insight
SABCS23 Day 1 Highlights by Oncology Brothers
Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the first day's…
Nov 8, 2023, 18:09 | Societies
ASCO has been awarded an $11 million grant from PCORI to support a clinical trial co-led by Erica Mayer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "The American Society of Clinical Oncology (ASCO) has been awarded an $11…
12
All: 12 Posts: 1 - 10